Chemotherapy News and Research

Latest Chemotherapy News and Research

Precision medicine enhances prostate cancer treatment with genetic profiling

Precision medicine enhances prostate cancer treatment with genetic profiling

New project aims to study the combination of two therapies for pediatric brain cancer

New project aims to study the combination of two therapies for pediatric brain cancer

SwRI develops a unique technology to screen new DNA-targeting therapeutics

SwRI develops a unique technology to screen new DNA-targeting therapeutics

Symptom-triggered testing shows promise for identifying early-stage ovarian cancer

Symptom-triggered testing shows promise for identifying early-stage ovarian cancer

New exosome-based drug delivery system enhances ovarian cancer treatment

New exosome-based drug delivery system enhances ovarian cancer treatment

Weill Cornell Medicine secures $12.4 million grant for lymphoma research

Weill Cornell Medicine secures $12.4 million grant for lymphoma research

New targets for improved cancer immunotherapy

New targets for improved cancer immunotherapy

Early detection key to beating ovarian cancer

Early detection key to beating ovarian cancer

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

New advances in Hodgkin's lymphoma treatment offer hope for affected individuals

Novel exosome-based drug delivery system for synergistic cancer treatment

Novel exosome-based drug delivery system for synergistic cancer treatment

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

Key insights on diagnosis and treatment of cardiac sarcomas

Key insights on diagnosis and treatment of cardiac sarcomas

Review explores potential for improved use of anti-angiogenic agents in cancer therapy

Review explores potential for improved use of anti-angiogenic agents in cancer therapy

Insilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment

Insilico Medicine's pan-TEAD inhibitor ISM6331 receives FDA IND clearance for mesothelioma treatment

Drug shows new promise in treating breast cancer with brain metastases or recurrent glioblastoma

Drug shows new promise in treating breast cancer with brain metastases or recurrent glioblastoma

Review of fasting-mimicking diets in cancer treatment

Review of fasting-mimicking diets in cancer treatment

Sensory nerves drive breast cancer growth and spread, study reveals

Sensory nerves drive breast cancer growth and spread, study reveals

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

Small-town patients face big hurdles as rural hospitals cut cancer care

Small-town patients face big hurdles as rural hospitals cut cancer care

FDA approves vorasidenib for Grade 2 gliomas with IDH mutations

FDA approves vorasidenib for Grade 2 gliomas with IDH mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.